Document Detail

Vaginal delivery of contraceptives.
MedLine Citation:
PMID:  16296797     Owner:  NLM     Status:  MEDLINE    
Although a steady increase in contraceptive use has been observed both in developed and less-developed countries, the large number of unplanned pregnancies may indicate that the contraceptive needs of a significant percentage of couples have so far not been met. Several new contraceptive products have reached the market during the last 2 years. Among these is a new contraceptive vaginal ring, which has become available for prescription. This new female method has been developed to expand the contraceptive choices available to couples. This review will address the specifics of the vaginal route for delivering contraceptive steroids and describe the various systems available or under evaluation.
Regine Sitruk-Ware
Related Documents :
11547527 - Factors determining the occurrence of unwanted pregnancies.
22720087 - Work-related maternal risk factors and the risk of pregnancy induced hypertension and p...
16604727 - Contraception counts: ranking state efforts.
4726947 - Sexuality, contraception and pregnancy in a high-school population.
3391427 - Obstetrical characteristics of a loss of end-diastolic velocities in the fetal aorta an...
1345037 - Valproic acid-induced placental and teratogenic effects in rats.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on drug delivery     Volume:  2     ISSN:  1742-5247     ISO Abbreviation:  Expert Opin Drug Deliv     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-11-21     Completed Date:  2005-12-20     Revised Date:  2009-11-17    
Medline Journal Info:
Nlm Unique ID:  101228421     Medline TA:  Expert Opin Drug Deliv     Country:  England    
Other Details:
Languages:  eng     Pagination:  729-36     Citation Subset:  IM    
Center for Biomedical Research, Population Council, New York, NY 10021, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptive Agents / administration & dosage*,  adverse effects
Contraceptive Devices, Female*
Drug Design
Estrogens / administration & dosage
Ovulation / drug effects
Progesterone / administration & dosage
Spermatocidal Agents / administration & dosage
Vagina / metabolism*
Reg. No./Substance:
0/Contraceptive Agents; 0/Estrogens; 0/Gels; 0/Hydrogels; 0/Spermatocidal Agents; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Delivery of plant-derived vaccines.
Next Document:  Delivery of therapeutic proteins to the mucosa using genetically modified microflora.